Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Drugs Made In America Acquisition Corp.

Get SEC filing alerts via email and in your feed for Drugs Made In America Acquisition Corp.

DMAA DMAAU DMAAR

Drugs Made In America Acquisition Corp.

About Drugs Made In America Acquisition Corp.

A special purpose acquisition company (SPAC) incorporated in the Cayman Islands, Drugs Made in America Acquisition Corp. aims to identify and acquire a leading pharmaceutical business in the United States. Its focus is on building a fully integrated, domestic drug manufacturing platform to enhance supply chain resilience, reduce reliance on foreign sources, and address drug shortages. The company leverages industry expertise, strategic acquisitions, and public market access to create value in the pharmaceutical sector.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Drugs Made In America Acquisition Corp.

1
1
Drugs Made In America Acquisition Corp. Drugs Made In America Acquisition Corp. Reports Q1 2026 Financial Results and Business Combination Plans

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
Drugs Made In America Acquisition Corp. Drugs Made In America Acquisition Corp. Reports $5.9 Million Net Income for Fiscal Year 2025

Via official filing (AI summary) | about 2 months ago | 0 comments

3
1
Drugs Made In America Acquisition Corp. Drugs Made In America Acquisition Corp. Reports Q3 2025 Net Income of $2.18 Million

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Drugs Made In America Acquisition Corp. Drugs Made In America Acquisition Corp. Reports $3.54 Million Net Income for First Half of 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Drugs Made In America Acquisition Corp. Drugs Made In America Acquisition Corp. Reports Q1 2025 Financial Results and IPO Details

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Drugs Made In America Acquisition Corp. Drugs Made In America Acquisition Corp. Reports IPO Success and Strategic Focus on Pharmaceutical Sector

Via official filing (AI summary) | about 1 year ago | 0 comments